Peania, January 24th, 2020 Transaction Announcement

Peania, January 24th, 2020 – Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.’s Executive Chairman, Mr. Athanasios Lavidas, proceeded with the following stock purchase : on 21/01/2020 purchased 100 Lavipharm S.A. common registered shares amounting to € 23,00, on 22/1/2020 60000 Lavipharm S.A. common registered shares amounting to € 15.600,00, and on 24/1/202 42.376 Lavipharm S.A. common registered shares amounting to € 11.017,76.

Η Υποβολή Στάλθηκε με αριθμό πρωτοκόλλου: 2020/EXAE/H/609

Η Υποβολή Στάλθηκε με αριθμό πρωτοκόλλου: 2020/EXAE/H/611

Η Υποβολή Στάλθηκε με αριθμό πρωτοκόλλου: 2020/EXAE/H/613

οι γνωστοποιήσεις για την T&A στην Ε/Κ με αρ. Πρωτ. 10324, 10326 και 10327